M. Pfütze

Clinical response of severe mechanobullous epidermolysis bullosa acquisita to combined treatment with immunoadsorption and rituximab (anti-CD20 monoclonal antibodies).

R. Eming, K. Reich, M. Hertl, 2007, Archives of dermatology.

Recommendations for the use of rituximab (anti‐CD20 antibody) in the treatment of autoimmune bullous skin diseases §

D. Zillikens, R. Eming, M. Goebeler, 2008, Journal der Deutschen Dermatologischen Gesellschaft = Journal of the German Society of Dermatology : JDDG.

Lack of differences of motorcortical excitability in the morning as compared to the evening in juvenile myoclonic epilepsy—A study using transcranial magnetic stimulation

Martin Pfütze, Janine Reis, Hajo M. Hamer, 2007, Epilepsy Research.

IgG autoantibody reactivity against bullous pemphigoid (BP) 180 and BP230 in elderly patients with pruritic dermatoses

M. Hertl, G. Caldarola, C. Feliciani, 2009, The British journal of dermatology.

Introducing a novel Autoimmune Bullous Skin Disorder Intensity Score (ABSIS) in pemphigus.

R. Eming, M. Hertl, A. Niedermeier, 2007, European journal of dermatology : EJD.

Clinical and Immunological Follow-Up of Pemphigus Patients on Adjuvant Treatment with Immunoadsorption or Rituximab

R. Eming, M. Hertl, U. Kuhlmann, 2008, Dermatology.